簡介

本頁面提供了有關 Ralf Kuriyel 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Ralf Kuriyel已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:RGEN / Repligen Corporation Senior VP, R&D 20,062
如何解讀這些圖表

以下圖表顯示了在Ralf Kuriyel進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

歷史內部人交易

該表格顯示了由 Ralf Kuriyel 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2026-03-23 2026-03-05 4 RGEN REPLIGEN CORP
Common Stock
A - Award 5,284 20,062 35.76
2026-03-05 2026-03-04 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -42 14,778 -0.28 125.84 -5,285 1,859,664
2026-03-05 2026-03-04 4 RGEN REPLIGEN CORP
Common Stock
A - Award 125 14,820 0.85
2026-03-03 2026-03-02 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -923 14,695 -5.91 124.97 -115,347 1,836,434
2026-03-03 2026-02-27 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -444 15,618 -2.76 128.73 -57,156 2,010,505
2025-03-04 2025-03-03 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -386 16,062 -2.35 155.38 -59,977 2,495,714
2025-03-04 2025-03-03 4 RGEN REPLIGEN CORP
Common Stock
A - Award 4,826 16,448 41.52
2025-02-28 2025-02-27 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -391 11,622 -3.25 156.54 -61,207 1,819,308
2025-02-25 2025-02-24 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -275 12,013 -2.24 164.74 -45,304 1,979,022
2024-08-05 2024-08-02 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -175 12,288 -1.40 158.85 -27,799 1,951,949
2024-08-05 2024-08-02 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 175 12,463 1.42 86.10 15,068 1,073,064
2024-08-05 2024-08-02 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -6,973 12,288 -36.20 159.36 -1,111,217 1,958,216
2024-08-01 2024-08-01 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -4,465 19,261 -18.82 165.67 -739,717 3,190,970
2024-05-15 2024-05-14 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -534 23,726 -2.20 163.34 -87,224 3,875,405
2024-03-12 2024-03-11 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -3,517 24,260 -12.66 193.73 -681,348 4,699,890
2024-03-12 2024-03-11 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 1,271 27,777 4.80 86.10 109,433 2,391,600
2024-03-07 2024-03-07 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -386 26,506 -1.44 195.72 -75,548 5,187,754
2024-03-06 2024-03-04 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -135 26,892 -0.50 193.99 -26,189 5,216,779
2024-03-04 2024-03-01 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -453 27,027 -1.65 191.79 -86,881 5,183,508
2024-03-04 2024-02-29 4 RGEN REPLIGEN CORP
Common Stock
A - Award 404 27,480 1.49
2024-02-29 2024-02-27 4 RGEN REPLIGEN CORP
Common Stock
A - Award 3,520 27,076 14.94
2023-05-16 2023-05-16 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -710 23,556 -2.93 154.03 -109,361 3,628,331
2023-03-06 2023-03-03 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -1,247 24,266 -4.89 188.00 -234,436 4,562,008
2023-03-06 2023-03-03 4 RGEN REPLIGEN CORP
Common Stock
A - Award 3,591 25,513 16.38
2023-03-06 2023-03-02 4 RGEN REPLIGEN CORP
Common Stock
A - Award 3,468 21,922 18.79
2023-03-01 2023-02-28 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -358 18,454 -1.90 173.28 -62,034 3,197,709
2023-02-28 2023-02-28 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -458 18,812 -2.38 173.44 -79,436 3,262,753
2022-08-12 2022-08-11 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -4,040 19,270 -17.33 254.14 -1,026,726 4,897,278
2022-08-12 2022-08-11 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -800 23,310 -3.32 255.20 -204,160 5,948,712
2022-08-12 2022-08-11 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 646 24,110 2.75 86.10 55,621 2,075,871
2022-08-12 2022-08-11 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 1,354 23,464 6.12 59.52 80,590 1,396,577
2022-08-12 2022-08-11 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 2,000 22,110 9.95 33.05 66,100 730,736
2022-05-17 2022-05-13 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -712 20,110 -3.42 150.40 -107,085 3,024,544
2022-03-02 2022-02-28 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -1,584 20,822 -7.07 196.70 -311,573 4,095,687
2022-03-02 2022-02-28 4 RGEN REPLIGEN CORP
Common Stock
A - Award 4,234 22,406 23.30
2022-03-02 2022-02-28 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -473 18,172 -2.54 196.70 -93,039 3,574,432
2022-03-02 2022-02-27 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -477 18,645 -2.49 196.70 -93,826 3,667,472
2022-02-28 2022-02-24 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 2,723 2,723
2022-02-28 2022-02-24 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -188 19,122 -0.97 189.21 -35,571 3,618,074
2022-02-28 2022-02-24 4 RGEN REPLIGEN CORP
Common Stock
A - Award 2,126 19,310 12.37
2022-02-22 2022-02-17 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -175 17,184 -1.01 182.42 -31,924 3,134,705
2022-02-22 2022-02-17 4 RGEN REPLIGEN CORP
Common Stock
A - Award 450 17,359 2.66
2021-12-15 2021-12-14 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -445 16,909 -2.56 252.53 -112,376 4,270,030
2021-09-02 2021-08-30 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -4,001 17,354 -18.74 282.13 -1,128,802 4,896,084
2021-06-14 2021-06-10 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -1,045 2,092 -33.31
2021-06-14 2021-06-10 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -2,557 1,354 -65.38
2021-06-14 2021-06-10 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -6,802 21,355 -24.16 189.19 -1,286,870 4,040,152
2021-06-14 2021-06-10 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 1,045 28,157 3.85 86.10 89,974 2,424,318
2021-06-14 2021-06-10 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 2,557 27,112 10.41 59.52 152,193 1,613,706
2021-05-18 2021-05-14 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -710 24,555 -2.81 172.29 -122,326 4,230,581
2021-03-12 2021-03-10 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -150 3,911 -3.69
2021-03-12 2021-03-10 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -5,850 0 -100.00
2021-03-12 2021-03-10 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -2,000 2,000 -50.00
2021-03-12 2021-03-10 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -1,004 25,265 -3.82 192.13 -192,899 4,854,164
2021-03-12 2021-03-10 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -642 26,269 -2.39 191.33 -122,834 5,026,048
2021-03-12 2021-03-10 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -6,354 26,911 -19.10 190.08 -1,207,768 5,115,243
2021-03-12 2021-03-10 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 150 33,265 0.45 59.52 8,928 1,979,933
2021-03-12 2021-03-10 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 5,850 33,115 21.46 33.87 198,140 1,121,605
2021-03-12 2021-03-10 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 2,000 27,265 7.92 33.05 66,100 901,108
2021-03-08 2021-03-04 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -700 25,265 -2.70 190.06 -133,042 4,801,866
2021-03-08 2021-03-04 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -600 25,965 -2.26 191.20 -114,720 4,964,508
2021-03-08 2021-03-04 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -350 26,565 -1.30 192.24 -67,284 5,106,856
2021-03-08 2021-03-04 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -25 26,915 -0.09 194.30 -4,858 5,229,584
2021-03-08 2021-03-04 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -400 26,940 -1.46 196.23 -78,492 5,286,436
2021-02-26 2021-02-24 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 2,035 2,035
2021-02-26 2021-02-24 4 RGEN REPLIGEN CORP
Common Stock
A - Award 1,686 27,340 6.57
2020-12-18 2020-12-16 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -435 25,654 -1.67 186.18 -80,988 4,776,262
2020-08-10 2020-08-06 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -5,000 5,850 -46.08
2020-08-10 2020-08-06 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -5,000 26,089 -16.08 153.79 -768,950 4,012,227
2020-08-10 2020-08-06 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 5,000 31,089 19.17 33.87 169,350 1,052,984
2020-05-19 2020-05-15 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -435 26,089 -1.64 140.69 -61,200 3,670,461
2020-05-15 2020-05-13 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -2,000 10,850 -15.56
2020-05-15 2020-05-13 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -6,000 4,000 -60.00
2020-05-15 2020-05-13 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -95 26,524 -0.36 128.55 -12,212 3,409,660
2020-05-15 2020-05-13 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -6,293 26,619 -19.12 128.02 -805,630 3,407,764
2020-05-15 2020-05-13 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -1,612 32,912 -4.67 126.88 -204,531 4,175,875
2020-05-15 2020-05-13 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 2,000 34,524 6.15 33.87 67,740 1,169,328
2020-05-15 2020-05-13 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 6,000 32,524 22.62 33.05 198,300 1,074,918
2020-03-05 2020-03-04 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -1,905 26,524 -6.70 90.99 -173,336 2,413,419
2020-03-05 2020-03-04 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -650 28,429 -2.24 90.08 -58,552 2,560,884
2020-03-05 2020-03-03 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -450 29,079 -1.52 88.35 -39,758 2,569,130
2020-03-02 2020-02-27 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 3,137 3,137
2020-03-02 2020-02-27 4 RGEN REPLIGEN CORP
Common Stock
A - Award 3,216 29,529 12.22
2020-02-27 2020-02-26 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -195 26,313 -0.74 86.60 -16,887 2,278,706
2019-12-18 2019-12-16 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -295 26,508 -1.10 90.43 -26,677 2,397,118
2019-06-11 2019-02-28 4/A RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 4,061 4,061
2019-05-15 2019-05-13 4 RGEN REPLIGEN CORP
Common Stock
A - Award 8,000 26,803 42.55
2019-03-05 2019-03-05 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -2,240 18,803 -10.64 58.53 -131,107 1,100,540
2019-03-05 2019-03-01 4 RGEN REPLIGEN CORP
Common Stock
A - Award 4,700 21,043 28.76
2019-03-04 2019-02-28 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 4,042 4,042
2019-03-04 2019-02-28 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -185 16,343 -1.12 59.16 -10,945 966,852
2019-03-04 2019-02-28 4 RGEN REPLIGEN CORP
Common Stock
A - Award 4,234 16,528 34.44
2018-12-20 2018-12-18 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -311 12,294 -2.47 54.44 -16,931 669,285
2018-03-06 3/A RGEN REPLIGEN CORP
Common Stock
5,962
2018-03-05 2018-03-01 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 12,850 12,850
2018-03-05 2018-03-01 4 RGEN REPLIGEN CORP
Common Stock
A - Award 6,643 12,605 111.42
2018-03-05 3 RGEN REPLIGEN CORP
Common Stock
11,924
2018-03-05 3 RGEN REPLIGEN CORP
Common Stock
11,924
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)